SCHEMBL5575775

SCHEMBL5575775

CCOC(=O)c1c(C)cccc1C1CN(Cc2ccccc2)CC1C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.45
MAPT P10636 2/20 0.45
MEN1 O00255 1/20 0.45
ADORA1 P30542 1/20 0.45
KMT2A Q03164 1/20 0.45
S1PR5 Q9H228 3/20 0.43
S1PR1 P21453 2/20 0.43
USP30 Q70CQ3 1/20 0.43
MAPK1 P28482 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.40
RORC P51449 1/20 0.40
SIGMAR1 Q99720 1/20 0.40
SCN4A P35499 2/20 0.40
TRPC5 Q9UL62 1/20 0.40
PRMT1 Q99873 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4484948 0.86 TSHR (0.46) LMNAMAPTMEN1ADORA1KMT2A
SCHEMBL1897605 0.84 S1PR5 (0.49) S1PR5S1PR1RORCSCN4A
SCHEMBL13041176 0.84 S1PR5 (0.49) S1PR5S1PR1RORCSCN4A
SCHEMBL27042490 0.82 PRMT1 (0.50) LMNAMEN1KMT2AS1PR5S1PR1
SCHEMBL30728803 0.82 PRMT1 (0.50) LMNAMEN1KMT2AS1PR5S1PR1
SCHEMBL30728773 0.82 PRMT1 (0.50) LMNAMEN1KMT2AS1PR5S1PR1
SCHEMBL1896746 0.81 USP30 (0.51) S1PR5S1PR1USP30SMN1; SMN2RORC
SCHEMBL4480859 0.80 MAPT (0.41) LMNAMAPTMEN1ADORA1KMT2A
SCHEMBL852497 0.80 S1PR5 (0.44) S1PR5S1PR1USP30RORCSIGMAR1
SCHEMBL4465368 0.76 FAAH (0.43) MEN1KMT2AS1PR5S1PR1RORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1778225-A2 PYRROLO(OXO)ISOQUINOLINES AS 5HT LIGANDS Bristol-Myers Squibb Company (US) 2007-05-02 EP disclosed
WO-2006019886-A2 PYRROLO(OXO)ISOQUINOLINES AS 5HT LIGANDS BRISTOL-MYERS SQUIBB COMPANY (US) 2006-02-23 WO disclosed